Related Experiment Videos
Hepatic angiosarcoma in a patient with essential thrombocythaemia and Budd-Chiari syndrome
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib.
BMC pharmacology & toxicology·2020
Delayed hemolytic transfusion reaction in the French hemovigilance system.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2019
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
[Is the research of posttransfusional alloantibodies still relevant?]
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2017
Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
European journal of cancer (Oxford, England : 1990)·2026
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
European journal of cancer (Oxford, England : 1990)·2026
Development of an age specific EORTC questionnaire to assess the health-related quality of life (HRQOL) of children with cancer aged 8-14 years - a mixed-methods content elicitation phase I & II EORTC QLG study.
European journal of cancer (Oxford, England : 1990)·2026
Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial.
European journal of cancer (Oxford, England : 1990)·2026
Older adults with resectable gastric cancer undergoing perioperative chemotherapy or preoperative chemoradiotherapy plus perioperative chemotherapy: A secondary analysis of the AGITG TOPGEAR phase III trial.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.
European journal of cancer (Oxford, England : 1990)·2026
Transforming Hemophilia Treatment With Novel Rebalancing Agents: Clinical Studies and Practical Perspectives.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Targeting Thrombopoietin/MPL Signaling to Mitigate JAK2V617F-Driven Cardiac Microvascular Disease.
Arteriosclerosis, thrombosis, and vascular biology·2026
Machine Learning-Based Prediction of Hemoglobin Variability in Patients with Chronic Kidney Disease Receiving Erythropoiesis-Stimulating Agents: A Real-World Retrospective Study.
International journal of nephrology and renovascular disease·2026